Bionet Valuation Multiples

Bionet is valued at $73M as of November 2026, a 1.6x revenue multiple. In the last fiscal year, Bionet revenue was $38M and Bionet EBITDA was $2M.

Bionet Overview

About Bionet

Bionet Corp provides blood bank and stem cell services. It is a preservation center for stem cells such as Umbilical Cord Mesenchymal Stem Cells and Dental Pulp Stem Cell Stem.


Founded

2000

HQ

Taiwan

Employees

190

Financials (Last FY)

Revenue: $38M
EBITDA: $2M

EV

$62M

Valuation Multiples

Start free trial

Valuation Multiples for 15K+ Public Comps

AdidasAirbnbAmazonCiscoCoca-ColaDellDropboxIBMIntelMcDonaldsNikeNVIDIASamsungSpotifyTeslaToyota
Browse Valuation Multiples

Bionet Financials

Bionet reported last fiscal year revenue of $38M and EBITDA of $2M.

In the same fiscal year, Bionet generated $21M in gross profit, $2M in EBITDA, and $2M in net income.


Bionet P&L

In the most recent fiscal year, Bionet reported revenue of $38M and EBITDA of $2M.

Bionet is profitable as of last fiscal year, with gross margin of 55%, EBITDA margin of 5%, and net margin of 4%.

See analyst estimates for Bionet
Last FY2025202620272028
Revenue$38M$38M
Gross Profit$21M$21M
Gross Margin55%55%
EBITDA$2M$2M
EBITDA Margin5%5%
EBIT Margin(1%)(1%)
Net Profit$2M$2M
Net Margin4%4%
Net Debt($4M)-

Financial data powered by Morningstar, Inc.

Bionet Stock Performance

Bionet has current market cap of $73M, and enterprise value of $62M.

Market Cap Evolution


Bionet's stock price is $1.40.

Bionet has an EPS (earnings per share) of $0.03.

See more trading valuation data for Bionet
EVMarket CapPrice 1DPrice 1MPrice 3MPrice 12MEPS
$62M$73M0.0%---$0.03

Benchmark Trading Valuation Multiples by Industry

Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.

Start Free Trial

Bionet Valuation Multiples

Bionet trades at 1.6x EV/Revenue multiple, and 35.8x EV/EBITDA.

See NTM and 2027E valuation multiples for Bionet

Bionet Financial Valuation Multiples

As of November 9, 2026, Bionet has market cap of $73M and EV of $62M.

Bionet has a P/E ratio of 46.4x.

Last FY2025202620272028
EV/Revenue1.6x1.6x
EV/EBITDA35.8x35.8x
EV/EBIT(168.3x)(168.3x)
EV/Gross Profit3.0x3.0x
P/E46.4x46.4x
EV/FCF128.5x128.5x

Multiples above and below 250x are considered non-meaningful (n/m). Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Verified Bionet Valuation Multiples

Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.

FactSetMorningstar
Start Free Trial

Bionet Margins & Growth Rates

In the most recent fiscal year, Bionet reported gross margin of 55%, EBITDA margin of 5%, and net margin of 4%.

See estimated margins and future growth rates for Bionet

Bionet Margins

Last FY2025202720282029
Gross Margin55%55%
EBITDA Margin5%5%
EBIT Margin(1%)(1%)
Net Margin4%4%
FCF Margin1%1%

Data powered by FactSet, Inc. and Morningstar, Inc.

Bionet Operational KPIs

Bionet's revenue per employee in the last FY averaged $0.2M, while opex per employee averaged $0.1M for the same period.

Access forward-looking KPIs for Bionet
Last FY2025202620272028
Revenue per Employee$0.2M-
Opex per Employee$0.1M-
S&M Expenses to Revenue27%27%
G&A Expenses to Revenue17%17%
R&D Expenses to Revenue12%12%
Opex to Revenue56%56%

Data powered by FactSet, Inc. and Morningstar, Inc.

Valuation Multiples Across 230+ Verticals

Bionet Competitors

EV/RevenueEV/EBITDA
Last FYLTM2027ELast FYLTM2027E

This data is available for Pro users. Sign up to see all Bionet competitors and their valuation data.

Start Free Trial

Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples

Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.

Start Free Trial

About Bionet

When was Bionet founded?Bionet was founded in 2000.
Where is Bionet headquartered?Bionet is headquartered in Taiwan.
How many employees does Bionet have?As of today, Bionet has over 190 employees.
Is Bionet publicly listed?Yes, Bionet is a public company listed on Taipei Exchange.
What is the stock symbol of Bionet?Bionet trades under 1784 ticker.
When did Bionet go public?Bionet went public in 2007.
Who are competitors of Bionet?Bionet main competitors include
What is the current market cap of Bionet?Bionet's current market cap is $73M.
What is the current revenue of Bionet?Bionet's last fiscal year revenue is $38M.
What is the current EV/Revenue multiple of Bionet?Current revenue multiple of Bionet is 1.6x.
Is Bionet profitable?No, Bionet is not profitable.
How many companies Bionet has acquired to date?Bionet hasn't acquired any companies yet (or none have been disclosed publicly).
In how many companies Bionet has invested to date?Bionet hasn't invested in any companies yet (or none have been disclosed publicly).

Start Your
Free Trial Today

Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.

Start Trial